Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sankar D Navaneethan

Showing results (91-100 of 281) with videos related to

Pageof 29
Sort By:
The Cochrane Database of Systematic Reviews|October 13, 2009
Atrial natriuretic peptide for preventing and treating acute kidney injurySagar U Nigwekar, Sankar D Navaneethan, Chirag R Parikh, et al.
International Journal of Cardiology|January 22, 2017
Cardiovascular impact in patients undergoing maintenance hemodialysis: Clinical management considerationsSrisakul Chirakarnjanakorn, Sankar D Navaneethan, Gary S Francis, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 15, 2026
Cardiovascular Outcomes and Acute Kidney Injury Risk with Combination Therapies in Type 2 Diabetes and Chronic Kidney DiseaseAbiodun Idowu, Kevin Bryan Lo, Roy Mathew, et al.
Southern Medical Journal|July 27, 2006
Concomitant intracranial aneurysm and carotid artery stenosis: A therapeutic dilemmaSankar D Navaneethan, Vijay Shri Kannan, Ayodele Osowo, et al.
Clinical Journal of the American Society of Nephrology : CJASN|December 17, 2008
Atrial natriuretic peptide for management of acute kidney injury: a systematic review and meta-analysisSagar U Nigwekar, Sankar D Navaneethan, Chirag R Parikh, et al.
Clinical Therapeutics|October 5, 2025
Empagliflozin Reduces Risk of Hospitalization in Patients With Chronic Kidney Disease in the EMPA-KIDNEY TrialAnastasia Uster, Nihar Desai, Sankar D Navaneethan, et al.
BMJ Open Diabetes Research & Care|July 27, 2021
Management of type 2 diabetes in chronic kidney diseaseJefferson L Triozzi, L Parker Gregg, Salim S Virani, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|November 20, 2022
Heart Failure-Type Symptom Score Trajectories in CKD: Findings From the Chronic Renal Insufficiency Cohort (CRIC) StudyCarl P Walther, Julia S Benoit, Nisha Bansal, et al.
The Cochrane Database of Systematic Reviews|July 10, 2009
Aldosterone antagonists for preventing the progression of chronic kidney diseaseSankar D Navaneethan, Sagar U Nigwekar, Ashwini R Sehgal, et al.
American Journal of Nephrology|January 22, 2020
Readmissions after Acute Kidney Injury during Left Ventricular Assist Device Implantation HospitalizationCarl P Walther, Wolfgang C Winkelmayer, Anita Deswal, et al.
Pageof 29

Showing results (91-100 of 281) with videos related to

Sort By:
Pageof 29
The Cochrane Database of Systematic Reviews|October 13, 2009
Atrial natriuretic peptide for preventing and treating acute kidney injurySagar U Nigwekar, Sankar D Navaneethan, Chirag R Parikh, et al.
International Journal of Cardiology|January 22, 2017
Cardiovascular impact in patients undergoing maintenance hemodialysis: Clinical management considerationsSrisakul Chirakarnjanakorn, Sankar D Navaneethan, Gary S Francis, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 15, 2026
Cardiovascular Outcomes and Acute Kidney Injury Risk with Combination Therapies in Type 2 Diabetes and Chronic Kidney DiseaseAbiodun Idowu, Kevin Bryan Lo, Roy Mathew, et al.
Southern Medical Journal|July 27, 2006
Concomitant intracranial aneurysm and carotid artery stenosis: A therapeutic dilemmaSankar D Navaneethan, Vijay Shri Kannan, Ayodele Osowo, et al.
Clinical Journal of the American Society of Nephrology : CJASN|December 17, 2008
Atrial natriuretic peptide for management of acute kidney injury: a systematic review and meta-analysisSagar U Nigwekar, Sankar D Navaneethan, Chirag R Parikh, et al.
Clinical Therapeutics|October 5, 2025
Empagliflozin Reduces Risk of Hospitalization in Patients With Chronic Kidney Disease in the EMPA-KIDNEY TrialAnastasia Uster, Nihar Desai, Sankar D Navaneethan, et al.
BMJ Open Diabetes Research & Care|July 27, 2021
Management of type 2 diabetes in chronic kidney diseaseJefferson L Triozzi, L Parker Gregg, Salim S Virani, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|November 20, 2022
Heart Failure-Type Symptom Score Trajectories in CKD: Findings From the Chronic Renal Insufficiency Cohort (CRIC) StudyCarl P Walther, Julia S Benoit, Nisha Bansal, et al.
The Cochrane Database of Systematic Reviews|July 10, 2009
Aldosterone antagonists for preventing the progression of chronic kidney diseaseSankar D Navaneethan, Sagar U Nigwekar, Ashwini R Sehgal, et al.
American Journal of Nephrology|January 22, 2020
Readmissions after Acute Kidney Injury during Left Ventricular Assist Device Implantation HospitalizationCarl P Walther, Wolfgang C Winkelmayer, Anita Deswal, et al.
Pageof 29